Published February 2, 2024
| Version v1
Dataset
Restricted
Efficacy of lanadelumab in angioedema due to acquired C1 inhibitor deficiency
Authors/Creators
- 1. Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy
- 2. Division of Internal Medicine, ASST Fatebenefratelli-Sacco, Luigi Sacco Hospital, Milan, Italy
- 3. Department of Biomedical and Clinical Sciences "Luigi Sacco," Università degli Studi di Milano, Milan, Italy
Description
Suffritti C, Sartorio S, Berra S, Janu VP, Caccia S, Zanichelli A. Efficacy of lanadelumab in angioedema due to acquired C1 inhibitor deficiency. J Allergy Clin Immunol Pract. 2023 Mar;11(3):963-965.e1. doi: 10.1016/j.jaip.2022.10.041. Epub 2022 Nov 13. PMID: 36379410.
Files
Restricted
The record is publicly accessible, but files are restricted. Log in to check if you have access.